Vertex (Buenos Aires, Argentina)
July 10, 2026
Marco Fierro, Abel Guerrero, Juan Toro
Over the past 30 years, psychopathology has shown a growing interest in the study of the self and its alterations from a phenomenological perspective, and a number of studies have appeared on the anomalous experience in schizophrenia. Publications on these topics are scarce in Spanish-language psychiatry. For this reason, this article presents a narrative review, first, of the concept of the...
Vertex (Buenos Aires, Argentina)
July 10, 2025
Micaela Dines, Adriana Bulacia, Paloma Bamondez et al.
Treatment-resistant major depression (TRD) poses a significant challenge in psychiatry due to the limited response to conventional therapies. Subanesthetic dose intravenous (IV) ketamine has emerged as an effective therapeutic option, providing rapid effects on depressive and suicidal symptoms. This article outlines the ketamine infusion protocol implemented in a general hospital, following...
Vertex (Buenos Aires, Argentina)
July 10, 2024
Mariana Zarankin, María S Pellegrini, Francisco Zenteno
2 citations
Major depression disorder is an entity with high prevalence and worldwide impact. Current treatments present a non-response rate of 15-30%, and certain adverse effects are seen like apathy syndrome and lack of emotional response. It is stated that the treatment with psilocybin fungi allows the possibility of dose reduction and suspension of classic psychotropic drugs and entails changes on an...
Vertex (Buenos Aires, Argentina)
July 10, 2023
Tamara Chernoff, Bruno Kliger, Dante Hernán Venturini
Traditional psychedelics, such as LSD, psilocybin, or DMT, are psychoactive compounds that exert their effects mainly through agonism over serotonergic receptors. In appropriate doses and contexts, they produce profound changes in the subjective experience, configuring altered states of consciousness that, upon reaching a critical point, involve the appearance of phenomena of mystical,...